CAS 122341-38-2: mTHPC
Description:mTHPC, or meta-tetrahydroxyphenylchlorin, is a chlorin derivative that is primarily used in photodynamic therapy (PDT) for cancer treatment. It exhibits a strong absorption in the red region of the spectrum, which is advantageous for therapeutic applications as it allows for deeper tissue penetration. mTHPC is characterized by its ability to generate reactive oxygen species upon light activation, leading to localized cell damage and tumor destruction. The compound is known for its high phototoxicity, which is effective against various types of cancer cells while minimizing damage to surrounding healthy tissues. Additionally, mTHPC has a relatively high lipophilicity, which influences its distribution and accumulation in tumor tissues. Its pharmacokinetics can be affected by factors such as formulation and administration route. Safety profiles indicate that while mTHPC can cause skin photosensitivity, its therapeutic benefits in oncology make it a valuable agent in the field of cancer treatment. Overall, mTHPC represents a significant advancement in targeted cancer therapies utilizing light-activated mechanisms.
Formula:C44H32N4O4
InChI:InChI=1S/C44H32N4O4/c49-29-9-1-5-25(21-29)41-33-13-15-35(45-33)42(26-6-2-10-30(50)22-26)37-17-19-39(47-37)44(28-8-4-12-32(52)24-28)40-20-18-38(48-40)43(36-16-14-34(41)46-36)27-7-3-11-31(51)23-27/h1-17,19,21-24,46-47,49-52H,18,20H2/b41-33-,41-34?,42-35?,42-37-,43-36?,43-38-,44-39-,44-40?
InChI key:InChIKey=LYPFDBRUNKHDGX-SOGSVHMOSA-N
SMILES:OC1=CC=CC(=C1)C2=C3N=C(C=C3)C(C=4C=CC=C(O)C4)=C5C=CC(N5)=C(C=6C=CC=C(O)C6)C7=NC(=C(C=8C=CC=C(O)C8)C9=CC=C2N9)CC7
- Synonyms:
- 3,3',3'',3'''-(2,3-Dihydroporphyrin-5,10,15,20-Tetrayl)Tetraphenol
- 3,3',3',3''-(7,8-Dihydroporphyrin-5,10,15,20-Tetrayl)Tetraphenol
- 3,3′,3′′,3′′′-(7,8-Dihydro-21H,23H-porphine-5,10,15,20-tetrayl)tetrakis[phenol]
- 3,3′,3′′,3′′′-(7,8-Dihydroporphyrin-5,10,15,20-tetrayl)tetraphenol
- 5,10,15,20-Tetra(M-Hydroxyphenyl)Chlorin
- 5,10,15,20-Tetrakis(m-hydroxyphenyl)chlorin
- 8-Dihydroporphyrin-5
- Foscan
- Fosgel
- Foslip
- See more synonyms
- Foslipos
- Fospeg
- Phenol, 3,3′,3′′,3′′′-(7,8-dihydro-21H,23H-porphine-5,10,15,20-tetrayl)tetrakis-
- Sml 1707
- m-Tetrahydroxyphenylchlorin
- mTHPC
- Temoporfin
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | Phenol, 3,3',3'',3'''-(7,8-dihydro-21H,23H-porphine-5,10,15,20-tetrayl)tetrakis- REF: IN-DA00174LCAS: 122341-38-2 | 95% | To inquire | Wed 16 Apr 25 |
![]() | Temoporfin REF: 54-BUP05345CAS: 122341-38-2 | 99.7% | 544.00 €~1,139.00 € | Thu 17 Apr 25 |
![]() | Temoporfin REF: TM-T17035CAS: 122341-38-2 | 99.71% | 49.00 €~777.00 € | Wed 23 Apr 25 |
![]() | Temoporfin, ~ 90% REF: TR-T017350CAS: 122341-38-2 | ~90% | 212.00 € | Mon 28 Apr 25 |
![]() | Temoporfin REF: 3D-XEA34138CAS: 122341-38-2 | Min. 95% | - - - | Discontinued product |

Phenol, 3,3',3'',3'''-(7,8-dihydro-21H,23H-porphine-5,10,15,20-tetrayl)tetrakis-
Ref: IN-DA00174L
2mg | 275.00 € | ||
5mg | 555.00 € |

Ref: 54-BUP05345
25mg | 544.00 € | ||
50mg | 807.00 € | ||
100mg | 1,139.00 € |

Temoporfin
Ref: TM-T17035
1mg | 49.00 € | ||
2mg | 70.00 € | ||
5mg | 105.00 € | ||
10mg | 177.00 € | ||
25mg | 364.00 € | ||
50mg | 540.00 € | ||
100mg | 777.00 € | ||
1mL*10mM (DMSO) | 159.00 € |

Temoporfin, ~ 90%
Controlled ProductRef: TR-T017350
5mg | 212.00 € |

Temoporfin
Ref: 3D-XEA34138
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information |